spin ph 7 login
spin ph 7 login
INGLEWOOD, Calif. (AP) — For the second straight season, the Philadelphia Eagles are headed to SoFi Stadium with a lengthy winning streak and a team that looks like one of the best in the NFC. The Los Angeles Rams (5-5) couldn't do much to slow them down last season, but they'll try again Sunday night with a young team that hopes to get where the Eagles (8-2) are already standing — atop their division with a six-game winning streak. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.WASHINGTON, Nov. 26, 2024 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. NASDAQ: ASPI ("ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today issued the following statement in response to a short seller report published on November 26, 2024 by Fuzzy Panda Research (“Fuzzy Panda”). Fuzzy Panda is a self-proclaimed short seller who stands to realize significant gains if the price of ASP Isotopes’s stock declines. Based upon ASP Isotopes’s and its legal counsel’s preliminary review and evaluation of the report, the Company believes the report includes speculative conjecture and claims that are inaccurate or filled with innuendo in an attempt to mislead investors about ASP Isotopes’s technology, leadership and future growth. Investors are encouraged to review the Company’s public filings made with the SEC. ASP Isotopes is in the process of commissioning three isotope enrichment facilities in South Africa and has hosted commercial partners and investors at these facilities. The first facility is scheduled to enrich Carbon-14 for use in healthcare and agrochemicals. The second facility is scheduled to enrich Silicon-28, which the Company believes will enable faster, more efficient semiconductors for use in artificial intelligence and quantum computing. The third facility is scheduled to enrich Ytterbium-176, a critically important raw material used in the production of radio-oncology therapies. ASP Isotopes values transparency and open communication. Canaccord Genuity’s analyst, George Gianarikas, will host a fire side chat with ASP Isotopes’s Chairman and Chief Executive Officer, Paul Mann, at 10am EST on November 27, 2024. Please contact your Canaccord Genuity sales representative for dial in details. About ASP Isotopes Inc. ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (“ASP technology”). The Company’s initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light isotopes). There is a growing demand for isotopes such as Silicon-28 for enabling quantum computing; Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare applications, as well as Chlorine-37, Lithium-6, Lithium-7 and Uranium-235 for green energy applications. The ASP Technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass molecules. For more information, please visit www.aspisotopes.com . Forward Looking Statements This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, without limitation, statements relating to the future of the Company’s enrichment technologies, the market demand for enriched isotopes, and the commencement of supply of enriched isotopes to customers. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations, and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy, and other future conditions. Forward-looking statements can be identified by words such as “believes,” “plans,” “anticipates,” “expects,” “estimates,” “projects,” “will,” “may,” “might,” and words of a similar nature. Examples of forward-looking statements include, among others but are not limited to, statements we make regarding expected operating results, such as future revenues and prospects from the potential commercialization of isotopes, future performance under contracts, and our strategies for product development, engaging with potential customers, market position, and financial results. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict, many of which are outside our control. Our actual results, financial condition, and events may differ materially from those indicated in the forward-looking statements based upon a number of factors. Forward-looking statements are not a guarantee of future performance or developments. You are strongly cautioned that reliance on any forward-looking statements involves known and unknown risks and uncertainties. Therefore, you should not rely on any of these forward-looking statements. There are many important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements, including the outcomes of various strategies and projects undertaken by the Company; the potential impact of laws or government regulations or policies in South Africa, the United Kingdom or elsewhere; our reliance on the efforts of third parties; our ability to complete the construction and commissioning of our enrichment plants or to commercialize isotopes using the ASP technology or the Quantum Enrichment Process; our ability to obtain regulatory approvals for the production and distribution of isotopes; the financial terms of any current and future commercial arrangements; our ability to complete certain transactions and realize anticipated benefits from acquisitions; contracts, dependence on our Intellectual Property (IP) rights, certain IP rights of third parties; and the competitive nature of our industry. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise. This press release includes market and industry data and forecasts that we obtained from internal research, publicly available information and industry publications and surveys. Industry publications and surveys generally state that the information contained therein has been obtained from sources believed to be reliable. Unless otherwise noted, statements as to our potential market position relative to other companies are approximated and based on third-party data and internal analysis and estimates as of the date of this press release. We have not independently verified this information, and it could prove inaccurate. Industry and market data could be wrong because of the method by which sources obtained their data and because information cannot always be verified with certainty due to the limits on the availability and reliability of raw data, the voluntary nature of the data-gathering process and other limitations and uncertainties. In addition, we do not know all of the assumptions regarding general economic conditions or growth that were used in preparing the information and forecasts from sources cited herein. No information in this press release should be interpreted as an indication of future success, revenues, results of operation, or stock price. All forward-looking statements herein are qualified by reference to the cautionary statements set forth herein and should not be relied upon. Contacts Jason Assad– Investor relations Email: Jassad@aspisotopes.com Telephone: 561-709-3043WVU football: Rodriguez returns to Morgantown as head coachChris Cenac Jr., the top center in the Class of 2025 according to the ESPN100, has committed to play for the Houston Cougars. The five-star recruit announced his decision Tuesday via the Bleacher Report's B/R App. Cenac previously said he wouldn't make his decision until the spring, but his stock soared over the summer after his impressive play on the Puma Pro 16 circuit with Dallas-based YGC, vaulting him into the national top-10 rankings. The 6-foot-10 New Orleans native was reportedly choosing between LSU, Auburn, Arkansas, Baylor, Kentucky, Tennessee and others before making the decision to join Cougars coach Kelvin Sampson's team. "I just like the coaching staff a lot, I like their plan to develop me and I like coming into a winning program," Cenac told 247Sports. "I'm looking forward to producing and just helping them win more. But the main thing was development and them being able to get me better so I can be ready for that next level." Cenac's rating of .9978 by 247Sports Composite makes him the Cougars' highest-rated commit in the modern era, according to multiple outlets. "They see me as a four who can kind of play all over the court and do everything," Cenac told 247Sports. "I can get rebounds, push the ball, shoot and play all over the floor." With Cenac joining other Houston commits like five-star shooting guard Isaiah Harwell, four-star point guard Kingston Flemings and three-star wing Bryce Jackson, Houston's Class of 2025 is ranked No. 2 in the nation by 247Sports and ESPN. --Field Level Media
A giraffe that lived her entire life at the Birmingham Zoo has died. Willow, a 16-year-old female reticulated giraffe , died Friday after becoming ill earlier in the week, according to a social media post by the zoo. The zoo said the giraffe had not been doing well, and her appetite continued to decline. She had an exam Thursday night which went well, according to the zoo, and was given fluids and antibiotics. The zoo post said, "After the exam, Willow did not get back up and quietly passed Friday morning December 27th, despite the heroic efforts of our animal care and animal health staff. The specific cause remains unknown, but a necropsy has been performed and tissues have been sent for evaluation." Willow was born at the Birmingham Zoo in 2008. Zoo personnel said she was a special animal and an amazing ambassador for her species. >> WVTM 13 ON-THE-GO: Download our app for free
Aries Yearly Horoscope 2025 prediction says a mixed bag of opportunities
Real Madrid’s big stars turned on the style to revive the Spanish giant’s faltering Champions League title defense on Tuesday. Galacticos Kylian Mbappe, Vinicius Junior and Jude Bellingham all scored in a thrilling 3-2 win at Italian league leader Atalanta. But Madrid still had to ride its luck as Mateo Retegui fired over from in front of goal in stoppage time when handed a golden chance to level the game. Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Get any of our free email newsletters — news headlines, obituaries, sports, and more.Investors threaten to call in police over huge losses after collapse of Alastair Campbell son's football betting syndicateNone
- Previous:
- Next: www spinph com
